{
  "ptid_time": "007_S_6515_2020-10-06",
  "img_path": "/data/qiuhui/data/adni/images/007_S_6515/2020-10-06/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 44,899 mm³, 7.9% above the reference mean. With a Z-score of 1.25 (89.4th percentile), this represents mild enlargement; hippocampal volume measures 6,992 mm³, 0.7% below the reference mean. With a Z-score of -0.36 (35.9th percentile), this represents normal volume ; whole brain volume measures 963,000 mm³, 5.9% above the reference mean. With a Z-score of 0.65 (74.3th percentile), this represents normal volume ; entorhinal cortex volume measures 3,934 mm³, 3.8% above the reference mean. With a Z-score of 0.35 (63.5th percentile), this represents normal volume ; fusiform gyrus volume measures 19,583 mm³, 33.7% above the reference mean. With a Z-score of 4.25 (100.0th percentile), this represents profound enlargement; middle temporal gyrus volume measures 16,672 mm³, 7.7% below the reference mean. With a Z-score of -4.02 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 91.9 years. Gender is Female. Education: 15 years. MMSE: 30.0. MoCA: 26.0. Logical Memory: 18.0. APOEε4 alleles: 0.0. Biomarker levels: Flobetaben (FBB): 1.22 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound atrophy in the middle temporal gyrus (Z-score -4.02, 0th percentile), which is strongly associated with Alzheimer's pathology, but other key regions (hippocampus, entorhinal cortex) are within normal ranges. The MMSE is intact (30/30), but the MoCA (26/30) suggests mild cognitive inefficiency, possibly due to age-related changes. The absence of APOE4 reduces genetic risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting imaging findings—severe middle temporal atrophy but normal hippocampal volume—and high MMSE despite MoCA decline in a very elderly patient).  \n\n*Note: Given the patient's age (91.9), some atrophy could reflect advanced aging rather than pathology. Close clinical correlation (e.g., longitudinal cognitive testing, FDG-PET/CSF biomarkers) would strengthen confidence.*",
  "timestamp": "2025-07-25T22:10:19.489297"
}